Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “ctDNA”

745 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 745 results

Testing effectiveness (Phase 2)WithdrawnNCT04611776
What this trial is testing

A Study Evaluating the Efficacy and Safety of Adjuvant Platinum-Doublet Chemotherapy, With or Without Atezolizumab, in Patients Who Are ctDNA Positive After Complete Surgical Resection of Stage IB to Select IIIB Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small Cell Lung
Hoffmann-La Roche
Not applicableLooking for participantsNCT05965024
What this trial is testing

Exploration on the Value of MRD Based on ctDNA Detection in Predicting Recurrence of Resected Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China 377
Not applicableLooking for participantsNCT06225505
What this trial is testing

Early Detection of Triple Negative Breast Cancer Relapse (CUPCAKE)

Who this might be right for
Triple Negative Breast Cancer
Institut Curie 450
Testing effectiveness (Phase 2)Looking for participantsNCT07410494
What this trial is testing

Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors

Who this might be right for
CancerBreast CancerNon-Small Cell Lung Cancer (NSCLC)+10 more
Essen Biotech 85
Not applicableActive Not RecruitingNCT06744075
What this trial is testing

Study of the Clearance of Minimal Residual Disease Measured at the End of First-line Treatment in Patients With Lymphoma

Who this might be right for
B-cell LymphomaHodgkin Lymphoma
Centre Henri Becquerel 108
Not applicableLooking for participantsNCT04957901
What this trial is testing

The Value of Monitoring Circulating Cell DNA (ctDNA) in Pediatric Lymphoma: A Prospective, Multicenter Clinical Study

Who this might be right for
Lymphoma
Sun Yat-sen University 60
Not applicableUnknownNCT02997241
What this trial is testing

Colon Cancer Treatment Decisions and Recurrence Predicting

Who this might be right for
Colonic Neoplasms
MyGenostics Inc., Beijing 500
Not applicableStudy completedNCT03172156
What this trial is testing

CtDNA Dynamic Monitoring and Its Role of Prognosis in Stage I NSCLS by NGS

Who this might be right for
Non-small Cell Lung Cancer Stage I
Sun Yat-sen University 100
Not applicableWithdrawnNCT04670588
What this trial is testing

Response Assessment by Circulating Tumor DNA in Patients With Locally Advanced Rectal Cancer

Who this might be right for
Rectal Cancer
Medical College of Wisconsin
Testing effectiveness (Phase 2)WithdrawnNCT06050954
What this trial is testing

A Pilot Study of Circulating Tumor DNA Adaptive Risk Maintenance Approach for Bladder Cancer (CARMA)

Who this might be right for
Metastatic Urothelial Carcinoma
Fox Chase Cancer Center
Not applicableEnded earlyNCT06290856
What this trial is testing

Clinical Utility of Selected Circulating Tumor DNA Assays in Patients With Advanced Malignancy

Who this might be right for
Metastatic Colorectal CancerPancreas AdenocarcinomaCholangiocarcinoma
Oslo University Hospital 16
Not applicableUnknownNCT05814224
What this trial is testing

Monitoring luminAl Breast Cancer Through the Evaluation of Mutational and epiGeNEtic alteraTIons of Circulating ESR1 DNA

Who this might be right for
Hormone Receptor Positive Breast CarcinomaBreast NeoplasmsNeoplasms, Breast+4 more
Centro di Riferimento Oncologico - Aviano 164
Testing effectiveness (Phase 2)Looking for participantsNCT05334277
What this trial is testing

Furmonertinib Monotherapy and Combination Therapy in Advanced EGFR Mutant NSCLC With Uncleared ctDNA

Who this might be right for
Non-small Cell Lung Cancer
Sun Yat-sen University 280
Not applicableStudy completedNCT02623257
What this trial is testing

EGFR Mutations on ctDNA in Patients With Advanced NSCLC

Who this might be right for
Non-small Cell Lung Cancer Stage IIINon-Small-Cell Lung Cancer Metastatic
First People's Hospital of Hangzhou 1,055
Not applicableUnknownNCT03042000
What this trial is testing

Multicenter, Prospective, RCT：Investigation of Combined Modality Therapy for Locally Advanced Mid/Low Rectal Cancer.

Who this might be right for
Rectal Cancer, AdenocarcinomaNeoadjuvant Chemoradiation
Peking Union Medical College Hospital 1,200
Not applicableLooking for participantsNCT05788744
What this trial is testing

Implementing ctDNA and Circular DNA in Patients With Localized Pancreatic Cancer

Who this might be right for
Resectable Pancreatic Cancer
Copenhagen University Hospital at Herlev 1,000
Testing effectiveness (Phase 2)Looking for participantsNCT05419089
What this trial is testing

The Sinai Robotic Surgery Trial in HPV-related Oropharyngeal Squamous Cell Carcinoma (SIRS 2.0 Trial)

Who this might be right for
HPV-positive Oropharyngeal Squamous Cell Carcinoma
Icahn School of Medicine at Mount Sinai 83
Not applicableLooking for participantsNCT03702309
What this trial is testing

Liquid Biopsy Evaluation and Repository Development at Princess Margaret

Who this might be right for
CancerBreast CancerLung Cancer+15 more
University Health Network, Toronto 2,500
Testing effectiveness (Phase 2)Active Not RecruitingNCT03653052
What this trial is testing

Do Changes in ctDNA Predict Response for Patients With Oesophageal Cancer Receiving Durvalumab

Who this might be right for
Oesophageal Cancer
Simon C Pacey, MD 18
Testing effectiveness (Phase 2)UnknownNCT06315686
What this trial is testing

The Dynamic Monitoring of Cerebrospinal Fluid ctDNA

Who this might be right for
NSCLC
Jiangsu Province Nanjing Brain Hospital 20
Load More Results